{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:48:36Z","timestamp":1762865316375},"reference-count":35,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bacillus anthracis protective antigen (PA), the B subunit of the binary anthrax toxin, binds to the cellular receptors capillary morphogenesis gene 2 protein and tumor endothelial marker 8 with high affinity. Both receptors are expressed on endothelial cells during angiogenesis. We sought to determine whether one could inhibit angiogenesis by interfering with the binding of these receptors to their endogenous ligands. Here, we show that wild-type PA inhibits both vascular endothelial growth factor\u2013induced and basic fibroblast growth factor\u2013induced angiogenesis at moderate but statistically significant levels. Structure-activity studies identified a PA mutant that exhibited markedly enhanced inhibition of angiogenesis and also inhibited tumor growth in vivo. This mutant, PASSSR, is unable to undergo normal cellular processing and, thus, remains bound to the surface receptor. Further mutation of PASSSR so that it does not bind to these cell surface receptors abolished its ability to inhibit angiogenesis. We conclude that high-affinity anthrax toxin receptor (ATR) ligands, such as PA and PASSSR, are angiogenesis inhibitors and that ATRs are useful targets for antiangiogenic therapy. These results also suggest that endothelial cell-binding proteins from additional pathogens may inhibit angiogenesis and raise the question of the role of such inhibition in pathogenesis. [Cancer Res 2007;67(20):9980\u20135]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-0829","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T21:39:01Z","timestamp":1192657141000},"page":"9980-9985","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mutant Anthrax Toxin B Moiety (Protective Antigen) Inhibits Angiogenesis and Tumor Growth"],"prefix":"10.1158","volume":"67","author":[{"given":"Michael S.","family":"Rogers","sequence":"first","affiliation":[{"name":"1Vascular Biology Program and Department of Ophthalmology, Children's Hospital, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Christensen","sequence":"additional","affiliation":[{"name":"2Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts and"},{"name":"3Department of Chemistry, Clemson University, Clemson, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"Birsner","sequence":"additional","affiliation":[{"name":"1Vascular Biology Program and Department of Ophthalmology, Children's Hospital, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Short","sequence":"additional","affiliation":[{"name":"1Vascular Biology Program and Department of Ophthalmology, Children's Hospital, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darran J.","family":"Wigelsworth","sequence":"additional","affiliation":[{"name":"2Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. John","family":"Collier","sequence":"additional","affiliation":[{"name":"2Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"D'Amato","sequence":"additional","affiliation":[{"name":"1Vascular Biology Program and Department of Ophthalmology, Children's Hospital, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"key":"2022061623362252000_B1","doi-asserted-by":"crossref","unstructured":"Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. Identification of the cellular receptor for anthrax toxin. Nature\u20082001; 414: 225\u20139.","DOI":"10.1038\/n35101999"},{"key":"2022061623362252000_B2","doi-asserted-by":"crossref","unstructured":"Scobie HM, Rainey GJ, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A\u20082003; 100: 5170\u20134.","DOI":"10.1073\/pnas.0431098100"},{"key":"2022061623362252000_B3","doi-asserted-by":"crossref","unstructured":"Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun\u20081995; 63: 82\u20137.","DOI":"10.1128\/iai.63.1.82-87.1995"},{"key":"2022061623362252000_B4","doi-asserted-by":"crossref","unstructured":"Klimpel KR, Molloy SS, Thomas G, Leppla SH. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A\u20081992; 89: 10277\u201381.","DOI":"10.1073\/pnas.89.21.10277"},{"key":"2022061623362252000_B5","doi-asserted-by":"crossref","unstructured":"Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol\u20082003; 19: 45\u201370.","DOI":"10.1146\/annurev.cellbio.19.111301.140655"},{"key":"2022061623362252000_B6","doi-asserted-by":"crossref","unstructured":"Chauhan V, Bhatnagar R. Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor. Infect Immun\u20082002; 70: 4477\u201384.","DOI":"10.1128\/IAI.70.8.4477-4484.2002"},{"key":"2022061623362252000_B7","doi-asserted-by":"crossref","unstructured":"Cunningham K, Lacy DB, Mogridge J, Collier RJ. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A\u20082002; 99: 7049\u201353.","DOI":"10.1073\/pnas.062160399"},{"key":"2022061623362252000_B8","doi-asserted-by":"crossref","unstructured":"Lacy DB, Mourez M, Fouassier A, Collier RJ. Mapping the anthrax protective antigen binding site on the lethal and edema factors. J Biol Chem\u20082002; 277: 3006\u201310.","DOI":"10.1074\/jbc.M109997200"},{"key":"2022061623362252000_B9","doi-asserted-by":"crossref","unstructured":"Mogridge J, Cunningham K, Lacy DB, Mourez M, Collier RJ. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A\u20082002; 99: 7045\u20138.","DOI":"10.1073\/pnas.052160199"},{"key":"2022061623362252000_B10","doi-asserted-by":"crossref","unstructured":"Mourez M, Yan M, Lacy DB, et al. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc Natl Acad Sci U S A\u20082003; 100: 13803\u20138.","DOI":"10.1073\/pnas.2436299100"},{"key":"2022061623362252000_B11","doi-asserted-by":"crossref","unstructured":"Santelli E, Bankston LA, Leppla SH, Liddington RC. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature\u20082004; 430: 905\u20138.","DOI":"10.1038\/nature02763"},{"key":"2022061623362252000_B12","doi-asserted-by":"crossref","unstructured":"Lacy DB, Wigelsworth DJ, Melnyk RA, Harrison SC, Collier RJ. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A\u20082004; 101: 13147\u201351.","DOI":"10.1073\/pnas.0405405101"},{"key":"2022061623362252000_B13","doi-asserted-by":"crossref","unstructured":"Bradley KA, Mogridge J, Jonah G, Rainey A, Batty S, Young JA. Binding of anthrax toxin to its receptor is similar to \u03b1 integrin-ligand interactions. J Biol Chem\u20082003; 278: 49342\u20137.","DOI":"10.1074\/jbc.M307900200"},{"key":"2022061623362252000_B14","doi-asserted-by":"crossref","unstructured":"Bell SE, Mavila A, Salazar R, et al. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci\u20082001; 114: 2755\u201373.","DOI":"10.1242\/jcs.114.15.2755"},{"key":"2022061623362252000_B15","doi-asserted-by":"crossref","unstructured":"Premanandan C, Lairmore MD, Fernandez S, Phipps AJ. Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes. Microb Pathog\u20082006; 41: 193\u20138.","DOI":"10.1016\/j.micpath.2006.05.003"},{"key":"2022061623362252000_B16","doi-asserted-by":"crossref","unstructured":"Hanks S, Adams S, Douglas J, et al. Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet\u20082003; 73: 791\u2013800.","DOI":"10.1086\/378418"},{"key":"2022061623362252000_B17","doi-asserted-by":"crossref","unstructured":"Lee JY, Tsai YM, Chao SC, Tu YF. Capillary morphogenesis gene-2 mutation in infantile systemic hyalinosis: ultrastructural study and mutation analysis in a Taiwanese infant. Clin Exp Dermatol\u20082005; 30: 176\u20139.","DOI":"10.1111\/j.1365-2230.2004.01698.x"},{"key":"2022061623362252000_B18","doi-asserted-by":"crossref","unstructured":"Dowling O, Difeo A, Ramirez MC, et al. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet\u20082003; 73: 957\u201366.","DOI":"10.1086\/378781"},{"key":"2022061623362252000_B19","doi-asserted-by":"crossref","unstructured":"Wigelsworth DJ, Krantz BA, Christensen KA, Lacy DB, Juris SJ, Collier RJ. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem\u20082004; 279: 23349\u201356.","DOI":"10.1074\/jbc.M401292200"},{"key":"2022061623362252000_B20","doi-asserted-by":"crossref","unstructured":"St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science\u20082000; 289: 1197\u2013202.","DOI":"10.1126\/science.289.5482.1197"},{"key":"2022061623362252000_B21","doi-asserted-by":"crossref","unstructured":"Nanda A, Carson-Walter EB, Seaman S, et al. TEM8 interacts with the cleaved C5 domain of collagen \u03b13(VI). Cancer Res\u20082004; 64: 817\u201320.","DOI":"10.1158\/0008-5472.CAN-03-2408"},{"key":"2022061623362252000_B22","doi-asserted-by":"crossref","unstructured":"Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, Terman BI. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res\u20082005; 305: 133\u201344.","DOI":"10.1016\/j.yexcr.2004.12.025"},{"key":"2022061623362252000_B23","doi-asserted-by":"crossref","unstructured":"Rmali KA, Puntis MC, Jiang WG. TEM-8 and tubule formation in endothelial cells, its potential role of its vW\/TM domains. Biochem Biophys Res Commun\u20082005; 334: 231\u20138.","DOI":"10.1016\/j.bbrc.2005.06.085"},{"key":"2022061623362252000_B24","doi-asserted-by":"crossref","unstructured":"Wei W, Lu Q, Chaudry GJ, Leppla SH, Cohen SN. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell\u20082006; 124: 1141\u201354.","DOI":"10.1016\/j.cell.2005.12.045"},{"key":"2022061623362252000_B25","doi-asserted-by":"crossref","unstructured":"Young JJ, Bromberg-White JL, Zylstra C, et al. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog\u20082007; 3: e27.","DOI":"10.1371\/journal.ppat.0030027"},{"key":"2022061623362252000_B26","doi-asserted-by":"crossref","unstructured":"Miller CJ, Elliott JL, Collier RJ. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry\u20081999; 38: 10432\u201341.","DOI":"10.1021\/bi990792d"},{"key":"2022061623362252000_B27","unstructured":"Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci\u20081996; 37: 1625\u201332."},{"key":"2022061623362252000_B28","doi-asserted-by":"crossref","unstructured":"O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell\u20081994; 79: 315\u201328.","DOI":"10.1016\/0092-8674(94)90200-3"},{"key":"2022061623362252000_B29","doi-asserted-by":"crossref","unstructured":"Rosovitz MJ, Schuck P, Varughese M, et al. Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J Biol Chem\u20082003; 278: 30936\u201344.","DOI":"10.1074\/jbc.M301154200"},{"key":"2022061623362252000_B30","doi-asserted-by":"crossref","unstructured":"Clamp AR, Jayson GC. The clinical potential of antiangiogenic fragments of extracellular matrix proteins. Br J Cancer\u20082005; 93: 967\u201372.","DOI":"10.1038\/sj.bjc.6602820"},{"key":"2022061623362252000_B31","doi-asserted-by":"crossref","unstructured":"Koo HM, VanBrocklin M, McWilliams MJ, Leppla SH, Duesbery NS, Woude GF. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc Natl Acad Sci U S A\u20082002; 99: 3052\u20137.","DOI":"10.1073\/pnas.052707699"},{"key":"2022061623362252000_B32","doi-asserted-by":"crossref","unstructured":"Liu S, Schubert RL, Bugge TH, Leppla SH. Anthrax toxin: structures, functions and tumour targeting. Expert Opin Biol Ther\u20082003; 3: 843\u201353.","DOI":"10.1517\/14712598.3.5.843"},{"key":"2022061623362252000_B33","doi-asserted-by":"crossref","unstructured":"Kirby JE. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun\u20082004; 72: 430\u20139.","DOI":"10.1128\/IAI.72.1.430-439.2004"},{"key":"2022061623362252000_B34","doi-asserted-by":"crossref","unstructured":"Moayeri M, Haines D, Young HA, Leppla SH. Bacillus anthracis lethal toxin induces TNF-\u03b1-independent hypoxia-mediated toxicity in mice. J Clin Invest\u20082003; 112: 670\u201382.","DOI":"10.1172\/JCI17991"},{"key":"2022061623362252000_B35","doi-asserted-by":"crossref","unstructured":"Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER. Pathogenic hantaviruses selectively inhibit \u03b23 integrin directed endothelial cell migration. Arch Virol\u20082002; 147: 1913\u201331.","DOI":"10.1007\/s00705-002-0852-0"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/20\/9980\/2574303\/9980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/20\/9980\/2574303\/9980.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:23:36Z","timestamp":1655439816000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/20\/9980\/533590\/Mutant-Anthrax-Toxin-B-Moiety-Protective-Antigen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,15]]},"references-count":35,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2007,10,17]]},"published-print":{"date-parts":[[2007,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-0829","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,15]]}}}